These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11869960)

  • 21. [Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia].
    Pivnik AV; Shtroiakovskiĭ DL; Medvedev PV; Moiseeva TN; Shklovskiĭ-Kordi NE; Skorokhod AA
    Ter Arkh; 1999; 71(7):24-7. PubMed ID: 10481863
    [No Abstract]   [Full Text] [Related]  

  • 22. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
    George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
    Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.
    Serefhanoglu S; Buyukasik Y; Goker H; Sayinalp N; Haznedaroglu IC; Aksu S; Ozcebe OI; Turgut M; Aslan R; Ozdemir E
    Leuk Res; 2010 Dec; 34(12):e317-9. PubMed ID: 20696473
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
    Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
    Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute lower limb ischemia revealing acute leukemia. Case report and review of the literature].
    Azghari A; Boukhbrine MK; Tijani Y; Bouziane Z; Idrissi R; Lekehal B; Sefiani Y; El Mesnaoui A; Boayad M; Ammar F; Bensaid Y
    J Mal Vasc; 2010 Feb; 35(1):43-6. PubMed ID: 19962259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon may reduce minimal residual disease of acute promyelocytic leukemia.
    Egyed M; Rumi G; Boros B; Páldi-Haris P; Földi J
    Leukemia; 2000 Jun; 14(6):1153. PubMed ID: 10865982
    [No Abstract]   [Full Text] [Related]  

  • 29. Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse.
    Haferlach T; Löffler H; Glass B; Gassmann W
    Clin Investig; 1993 Oct; 71(10):774-9. PubMed ID: 8305832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
    Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia.
    Abhyankar D; Nair R; Menon H; Kapoor B; Advani S
    Leuk Lymphoma; 2000 May; 37(5-6):635-7. PubMed ID: 11042527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
    Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
    Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
    [No Abstract]   [Full Text] [Related]  

  • 33. Central nervous system relapse in acute promyelocytic leukemia.
    Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
    Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
    de Botton S; Coiteux V; Chevret S; Rayon C; Vilmer E; Sanz M; de La Serna J; Philippe N; Baruchel A; Leverger G; Robert A; San Miguel J; Conde E; Sotto JJ; Bordessoule D; Fegueux N; Fey M; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2004 Apr; 22(8):1404-12. PubMed ID: 15084614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 36. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute colonic pseudo-obstruction (Ogilvie's syndrome) during induction treatment with chemotherapy and all-trans-retinoic acid for acute promyelocytic leukemia.
    Delmer A; Cymbalista F; Bauduer F; Martin A; Rio B; Fenaux P; Marie JP; Zittoun R
    Am J Hematol; 1995 May; 49(1):97-8. PubMed ID: 7741149
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term therapeutic outcome of patients with acute promyelocytic leukemia].
    Zhang L; Li R; Li DP; Liu YZ; Xu SC; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):15-8. PubMed ID: 17649719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Krishna R; Sorour Y; Goepel JR; Kirkbride P; Smith DJ; Ezaydi Y; Dalley CD; Snowden JA
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):769-71. PubMed ID: 18995171
    [No Abstract]   [Full Text] [Related]  

  • 40. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.